Blog

MSC Therapy for Diabetic Foot Ulcers: 2026 Mechanism, Hydrogel Delivery, and Real-World Trial Outcomes

2026 medical update on MSC therapy for diabetic foot ulcers: M2 macrophage polarization, EXO-miR3671 angiogenesis, hydrogel delivery, UC-MSC vs ADSC head-to-head, 47-RCT meta-analysis, and cost-effectiveness vs amputatio…

Aug 18, 2026

Allogeneic vs Autologous Stem Cells: What 2026 Evidence Says Is Better

2026 Q3 update on allogeneic vs autologous MSC: head-to-head trial data, donor-age impact, 2026 manufacturing advances, when each is preferred, the cost picture, and FAQ for patients in Thailand and Asia-Pacific.

Aug 17, 2026

Stem Cell Therapy for Osteoporosis: What 2026 Research Means for Women After Menopause

Osteoporosis after menopause affects millions of women. New 2026 research shows mesenchymal stem cells and exosomes can rebuild bone density safely. Here’s what patients need to know.

Aug 16, 2026

Exosome Therapy for ALS: A New Wave of Hope Arrives in Bangkok

If you or someone you love is living with ALS (Amyotrophic Lateral Sclerosis), you already know the hardest part of the diagnosis: being told to wait. Wait for research. Wait for trials. Wait for something to change. But…

Aug 15, 2026

Stem Cell Therapy for Dry Age-Related Macular Degeneration: Your 2026 Guide to Vision Restoration

Explore the latest 2026 research on stem cell therapy for dry Age-Related Macular Degeneration (AMD). Learn how RPE cell transplantation and clinical trials offer new hope for restoring vision. Consult Cell La Vie.

Aug 14, 2026

MSC Therapy for Burn Wounds and Chronic Skin Regeneration: 2026 Breakthroughs in Exosome-Based Healing

New 2026 research reveals UC-MSC exosomes combined with low-intensity pulsed ultrasound and curcumin-hydrogel systems achieve remarkable burn wound healing — including MRSA-infected wounds — through autophagy regulation,…

Aug 14, 2026

Stem Cells and Alzheimer’s Disease: A Patient’s Guide to What 2026 Research Shows

2026 patient guide to MSC therapy for Alzheimer’s disease: how it differs from lecanemab and donanemab, who is a candidate, what outcomes to expect, the 6 active clinical trials including NCT06775964 and the first MSC + …

Aug 13, 2026

Is Stem Cell Therapy Legal and Safe in Thailand? (2026 Patient Guide)

Is Stem Cell Therapy Legal and Safe in Thailand? For international patients considering regenerative treatments, traveling abroad for stem cell therapy brings both immense hope and important practical questions. As medic…

Aug 13, 2026

The First FDA-Approved Stem Cell Therapy for Type 1 Diabetes: What Zimislecel Means for Patients in 2026

Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026,…

Aug 13, 2026

MSC Exosome and Stem Cell Therapy for Psoriasis: 2026 Mechanism, Trials, and Clinical Landscape

5 MSC and exosome trials for psoriasis have reported completion; three 2026 mechanistic studies reveal novel Ang1/Tie2 angiogenesis mechanisms, engineered exosome-nanoparticle platforms, and culture medium optimization f…

Aug 13, 2026

MSC Therapy for Degenerative Disc Disease: A 2026 Meta-Analysis of Randomized Trials and the Cell-Free Exosome Frontier

A 2026 meta-analysis of 7 randomized trials confirms intradiscal MSC injections reduce chronic back pain and disability significantly. Meanwhile, bioengineered exosome therapies are redefining what cell-free disc regener…

Aug 12, 2026

MSC Therapy for Peripheral Arterial Disease and Critical Limb Ischemia: 2026 Clinical and Mechanistic Breakthroughs

CRISPR-edited MSCs, iPSC-derived cells, combinatorial cell therapy, and exosome-based approaches are transforming PAD/CLI treatment. Six landmark 2026 papers and five active clinical trials reviewed for clinicians and re…

Aug 12, 2026

Page 3 of 15 — 177 posts